Calvin Ding

Calvin Ding

Partner
Shanghai

Email [email protected]​hoganlovells.com

Phone +86 21 6122 3808

Fax +86 21 6122 3899

LanguagesEnglish, Mandarin

Practice groupLitigation, Arbitration, and Employment

Represents companies in corruption and conflicts of interest, trade compliance, and cybersecurity incident related matters across a wide array of industries.

Legal 500 China 2022 - Regulatory / Compliance

As a U.S.-trained attorney who has worked in China for over a decade, Calvin leverages his international background and local expertise to advise clients in navigating their most pressing and challenging regulatory, compliance, internal and government investigations, litigation and dispute resolution matters.

In the investigations space, Calvin has represented companies and their board committees in matters ranging from corruption and conflicts of interest, to trade compliance and cybersecurity incidents. These investigations span industries, and include work for market leaders in the life sciences, technology and telecommunications, chemicals, automotive, diversified industrials and retail sectors.

To help clients avoid problems, Calvin regularly advises on the design and implementation of comprehensive anti-corruption compliance programs, as well as providing guidance on pre-acquisition due diligence, risk assessments, and remediation. Having spent several years working on the day-to-day implementation of an FCPA compliance program in China to address what was then the largest FCPA case brought by the U.S. Government, Calvin has developed a keen understanding and anticipation for the ways the U.S. Government evaluates official corruption issues and the steps a company takes to forestall and address such problems. In addition, Calvin has served as a member of the anti-corruption compliance monitor team for a global medical device company during a 3-year resolution related to a World Bank Group investigation.

Awards and recognitions

2022

Life Sciences and Healthcare: Foreign Firms, Key Lawyer
Legal 500 China

2022

Regulatory / Compliance: Foreign Firms, Recommended Lawyer
Legal 500 China

Education and admissions

Education

J.D., University of Minnesota Law School, 2007

B.A. Economics and Government, Cornell University, 2003

Memberships

American Bar Association

Cornell Alumni Association of Shanghai

Bar admissions and qualifications

Indiana

Representative experience

Advising a multinational information services company in investigating and responding to a ransomware attack.

Advising a Chinese telecommunications company in relation to U.S. trade sanctions and the internal investigations stemming from such sanctions.

Conducting multiple investigations in the life sciences industry relating to allegations of improper sales incentives, channel stuffing, fraudulent expenses, off-label use, and drug re-sale.

Conducting due diligence for an international conglomerate involving entities in multiple jurisdictions, and advising on pre and post-closing actions relating to FCPA and Chinese anti-bribery laws.

Implementing an anti-corruption compliance program in China to address one of the largest FCPA investigations brought to date by the U.S. Government.*

Evaluating an international medical device manufacturer’s anti-corruption compliance programs and advising the company and an international financial institution on the adequacy of those programs.*

Establishing the Greater China anti-corruption compliance function of one of the largest hotel chains in the world with over 150 properties in China, Taiwan, Hong Kong, and Macau.*

Conducting due diligence for an international conglomerate involving businesses in multiple jurisdictions, and advising on pre and post-closing actions relating to FCPA and Chinese anti-bribery laws.*

Advising a leading e-commerce company on the implementation of anti-corruption policies and procedures, including the diligence and clearance of third party intermediaries and business partners.*

Defending one of the largest Chinese steel makers and achieving an unprecedented victory against allegations before the USITC involving antitrust, trade secret and false designation of origin claims.*

Acting as compliance monitor to an international medical device manufacturer to advise the company and a multilateral development bank on the contours and adequacy of anti-corruption programs.*

Representing the audit committee of a listed company in an internal investigation with respect to conflict of interest, breach of fiduciary duty, and FCPA issues arising out of whistleblower claims.*

Represented the audit committee of a listed company in an internal investigation conducted in response to media reports alleging breach of fiduciary duties and corruption.*

*Matter handled prior to joining Hogan Lovells.

Loading data